熱門資訊> 正文
RedHill Bizerma计划实施ADS比率变更
2024-08-16 22:23
- RedHill Biopharma (NASDAQ:RDHL) plans to implement a ratio change of the Co.'s ADSs to its non-traded ordinary shares from the current ratio of 1 ADS representing 400 ordinary shares to a new ratio of 1 ADS representing 10,000 ordinary shares.
- The anticipated first date of the ratio change is on or about August 20, 2024, and the Co.'s ADSs will continue to be traded on the Nasdaq under the symbol "RDHL" with a new CUSIP Number 757468301.
- For ADS holders, the ratio change will have the same effect as a one-for-25 reverse ADS split.
More on RedHill
- Financial information for RedHill
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
